Skip to content

Clinical trials

Muscular Atrophy trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy Country / region: Belgium Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20111
20131
20142
20152
20181
20202
20212
20222
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Unknown status2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Scholar Rock, Inc.2
Universiteit Antwerpen2
Dr F Duprez1
Eli Lilly and Company1
Frank Vandenabeele1
Hasselt University1
KU Leuven1
Provinciale Hogeschool Limburg1
University of Liege1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy19
Muscular Atrophy, Spinal5
Critical Illness4
Atrophy3
Bulbo-Spinal Atrophy, X-Linked3
Muscular Diseases3
Burns2
Myositis, Inclusion Body2
Neuromuscular Diseases2
Neuromuscular Manifestations2

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.